2009 Vaccine Research Seminars
Future Seminars | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
Seminars are held on the NIH campus in Building 40, Conference Rooms 1201 & 1203, on Tuesdays at 4:00 PM (except as noted).
Date
|
Name
|
Institution
|
Seminar
|
| June 23, 2009 |
Terry Tumpey |
CDC |
Mutations that affect the transmissibilty of influenza viruses |
| June 16, 2009 |
Nancy Sullivan |
VRC / NIAID / NIH |
Ebola virus immunity: Host defenses to deter an unwelcome guest |
| June 9, 2009 |
Michael Egan |
Profectus |
Making good on the promise of pDNA vaccines |
| June 2, 2009 |
Raul Andino |
Univ Calif San Francisco |
Virus diversity, evolution and rational vaccine |
| May 26, 2009 |
Steve Hoffman |
Sanaria |
Progress toward development of a metabolically active, non-replicating Plasmodium falciparummalaariasporozoite vaccine |
| May 19, 2009 |
Louis Picker |
Oregon Health SciUniv |
Memory T cell regulation in SIV pathogenesis and immunity |
| May 12, 2009 |
Robin Weiss |
University College London |
Parasitic tumor cells |
| May 5, 2009 |
Veffa Franchini |
NCI / NIH |
HIV Vaccines: What are we learning from failure in the macaque model? |
| April 28, 2009 |
Tom Quinn |
NIAID, Laboratory of Immunoregulation, Division of Intramural Research |
HIV infection in Africa: Subtype differences in pathogenesis and transmission |
| April 21, 2009 |
Leo Stamatatos |
SBRI |
Epitope specificities of cross-neutralizing antibody responses in HIV+ sera: implications for immunogen design |
| April 14, 2009 |
Eric Hunter |
Emory University |
Virus selection and adaptation following heterosexual transmission of HIV-1 in sub-Saharan Africa |
| March 31, 2009 |
Bob Doms |
University of Pennsylvania |
Targeting the glycan shield of HIV-1 |
| March 17, 2009 |
Carl June |
University of Pennsylvania |
Engineered T cells for HIV/AIDS |
| March 10, 2009 |
Paul Johnson NEPRC |
Harvard University |
New insights into protective immunity induced by live attenuated SIV |
| February 24, 2009 |
Amalio Telenti |
University of Lausanne |
Evolutionary genomics and susceptibility to HIV |
| February 17, 2009 |
Paul Offit |
Children’s Hosp. Philadelphia |
Communicating science to the public |
| February 3, 2009 |
James Binley |
Torrey Pines Inst. Mol. Med |
HIV neutralization and vaccine design |
| January 27, 2009 |
Paul Spearman |
Emory University |
HIV gag protein trafficking and particle assembly |
| January 13, 2009 |
George Shaw |
University of Alabama |
Transmitted/founder viruses in acute HIV-1 and SIV infection and their implications for vaccine development |
View Past Seminars
back to top